Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014

dc.contributor.author	So, Nadine W.
dc.contributor.author	Taira, Deborah
dc.date.accessioned	2017-04-11T19:46:38Z
dc.date.available	2017-04-11T19:46:38Z
dc.date.issued	2017-04-11
dc.description	Pdf
dc.description.abstract	Tricyclic antidepressants were the primary pharmacologic treatment for depression in the United States from the 1960s to the late 1980s. Since then, other classes of antidepressants, such as Selective Serotonin Reuptake Inhibitors, have replaced its use as first-line agents due to their more favorable side-effect profile and proven equal efficacy. Tricyclic antidepressants are included in the Beers Criteria because of their potentially harmful side effects in the elderly (e.g. cognitive impairment, delirium, sedation, and orthostatic hypotension). The purpose of this study is to evaluate the changes in prescribing of tricyclic antidepressants from 2013 to 2014 in Medicare beneficiaries.
dc.format.extent	1 poster
dc.identifier.uri	http://hdl.handle.net/10790/3015
dc.language.iso	en-US
dc.rights	This item is licensed under a Creative Commons License.
dc.subject	Antidepressive Agents, Tricyclic
dc.subject	Medicare Part D
dc.subject	Inappropriate Prescribing
dc.subject	Physicians' practice patterns
dc.title	Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014
dc.type	Image
dc.type	Other
dc.type.dcmi	Text

Files

Now showing 1 - 1 of 1

Now showing 1 - 1 of 1